(Q50892754)

24 March 2018

title

Antiresorptive therapy in asthmatic patients receiving high-dose inhaled steroids: a prospective study for 18 months. (English)

1 reference

24 March 2018

0 references

Wang WQ

1

1 reference

24 March 2018

Ip MS

series ordinal

2

1 reference

24 March 2018

Tsang KW

series ordinal

3

1 reference

24 March 2018

Lam KS

series ordinal

4

1 reference

24 March 2018

language of work or name

English

0 references

publication date

1 April 1998

1 reference

24 March 2018

number of pages

6

1 reference

The Journal of Allergy and Clinical Immunology

inferred from page(s)

published in

1 reference

24 March 2018

volume

101

1 reference

24 March 2018

issue

4 Pt 1

1 reference

24 March 2018

page(s)

445-450

1 reference

24 March 2018

Efficacy and safety of inhaled corticosteroids in asthma. Report of a workshop held in Eze, France, October 1992.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970351-3

7 January 2021

Adrenocortical suppression following treatment with beclomethasone and budesonide

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970351-3

7 January 2021

Inhaled beclomethasone decreases serum osteocalcin in postmenopausal asthmatic women

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970351-3

7 January 2021

Effects of dose and dosing schedule of inhaled budesonide on bone turnover

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970351-3

7 January 2021

Effects of inhaled budesonide on serum markers of bone metabolism in children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970351-3

7 January 2021

Decreased bone mineral density in premenopausal asthma patients receiving long-term inhaled steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970351-3

7 January 2021

Calcium supplements in the prevention of steroid-induced osteoporosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970351-3

7 January 2021

RADIOACTIVE CALCIUM KINETICS DURING HIGH CALCIUM INTAKE IN OSTEOPOROSIS.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970351-3

7 January 2021

Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970351-3

7 January 2021

Intermittent cyclical etidronate in the prevention of corticosteroid-induced bone loss

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970351-3

7 January 2021

The association of lifetime weight and weight control patterns with bone mineral density in an adult community.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970351-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970351-3

7 January 2021

Glucocorticoid-Induced Osteoporosis: Pathogenesis and Management

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970351-3

7 January 2021

Beclomethasone inhalation decreases serum osteocalcin concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970351-3

7 January 2021

Calcium intake and bone mass: a quantitative review of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970351-3

7 January 2021

Interaction of calcium nutrition and physical activity on bone mass in young women

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970351-3

7 January 2021

Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970351-3

7 January 2021

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970351-3

7 January 2021

Bone turnover during short course prednisolone treatment in patients with chronic obstructive airways disease

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970351-3

7 January 2021

Bone turnover during high dose inhaled corticosteroid treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970351-3

7 January 2021

The course of biochemical parameters of bone turnover during treatment with corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970351-3

7 January 2021

10.1016/S0091-6749(98)70351-3

Identifiers

DOI

1 reference

24 March 2018

1 reference

24 March 2018